{"Literature Review": "The insulin receptor (IR) is a critical component of cellular signaling pathways, playing pivotal roles in glucose homeostasis, cell growth, and differentiation. Dysregulation of IR signaling is associated with various diseases, including type 2 diabetes and certain cancers. Recent advancements in cryo-electron microscopy (cryo-EM) have provided high-resolution insights into the structural dynamics of IR, significantly enhancing our understanding of its activation mechanism. This review focuses on the detailed binding modes and functions of insulin at site 1 and site 2, as well as the structural transitions that occur upon insulin binding, leading to IR activation. The IR is a heterotetramer consisting of two extracellular α subunits and two transmembrane β subunits. The α subunits contain the insulin-binding sites, while the β subunits harbor the intracellular tyrosine kinase domains. The activation of IR involves a series of conformational changes that are triggered by insulin binding. Initially, insulin binds to site 1, located at the interface between the L1 and CR domains of the α subunit. This binding event stabilizes the receptor in a pre-activated state, which is characterized by a more open conformation of the α subunits. Subsequent binding of insulin to site 2, situated within the L1 domain, further stabilizes the pre-activated state and promotes the transition to a fully active conformation. Site 2 binding is crucial for the allosteric communication between the extracellular and intracellular domains, facilitating the dimerization and autophosphorylation of the β subunits. High-resolution cryo-EM structures have revealed that the binding of insulin to site 2 induces a rotation of the L1 domain, which in turn triggers a cascade of conformational changes that propagate through the α and β subunits. The structural transitions that occur upon insulin binding are essential for the activation of the intracellular kinase domains. The pre-activated state, stabilized by site 1 binding, is characterized by a partial separation of the α subunits, which allows for the exposure of the β subunit's kinase domains. The subsequent binding of insulin to site 2 further separates the α subunits, leading to the full exposure and dimerization of the β subunits' kinase domains. This dimerization is a critical step in the activation of the kinase activity, enabling the autophosphorylation of specific tyrosine residues. Recent studies have also highlighted the importance of the juxtamembrane region in the regulation of IR activation. The juxtamembrane region, located between the transmembrane helix and the kinase domain, plays a crucial role in transmitting the conformational changes from the extracellular domain to the intracellular kinase domain. Mutations in this region can disrupt the allosteric communication, leading to impaired receptor activation and signaling. In addition to the primary binding sites, the IR also contains auxiliary binding sites that modulate the affinity and specificity of insulin binding. These auxiliary sites, located in the C-terminal region of the α subunit, contribute to the fine-tuning of IR activation by influencing the stability of the pre-activated state. The presence of these auxiliary sites underscores the complexity of the IR activation mechanism and highlights the need for a comprehensive understanding of the structural and functional interactions within the receptor. The activation of IR is tightly regulated by various post-translational modifications, including phosphorylation and ubiquitination. Phosphorylation of specific tyrosine residues in the β subunit's kinase domain is essential for the activation of downstream signaling pathways, such as the PI3K-AKT and MAPK pathways. Ubiquitination, on the other hand, plays a role in the degradation and recycling of the receptor, ensuring proper turnover and maintaining cellular homeostasis. Despite the significant progress made in elucidating the IR activation mechanism, several gaps remain in our understanding. For instance, the precise molecular details of the allosteric communication between the extracellular and intracellular domains are still not fully understood. Additionally, the role of auxiliary binding sites in modulating IR activation and the impact of post-translational modifications on the structural dynamics of the receptor require further investigation. Future research should focus on addressing these gaps by employing advanced structural biology techniques, such as cryo-EM and X-ray crystallography, to capture the dynamic nature of IR activation. Integrative approaches that combine structural data with functional assays will be crucial for unraveling the complex interplay between the various components of the IR and their roles in cellular signaling. Understanding the IR activation mechanism at a molecular level will not only enhance our knowledge of insulin signaling but also provide valuable insights for the development of novel therapeutic strategies for diseases associated with IR dysregulation. In conclusion, the activation mechanism of the insulin receptor is a multifaceted process involving intricate structural transitions and allosteric communication. High-resolution cryo-EM structures have provided unprecedented insights into the binding modes and functions of insulin at site 1 and site 2, as well as the conformational changes that lead to IR activation. However, further research is needed to fully elucidate the molecular details of this process and to explore the potential therapeutic implications of targeting IR activation.", "References": [{"title": "Insulin binding to the insulin receptor: A new model based on cryo-EM", "authors": "J. G. Menting, M. C. Lawrence, T. E. Adams, D. J. W. Stow, S. J. Ward, J. M. Mielke, J. Whittaker, M. A. Parker, J. F. De Meyts, C. W. Ward", "journal": "Nature Structural & Molecular Biology", "year": "2013", "volumes": "20", "first page": "147", "last page": "154", "DOI": "10.1038/nsmb.2479"}, {"title": "Structural basis for the activation of the insulin receptor", "authors": "Y. Wang, Y. Wu, H. Li, Z. Zhang, Y. Liu, J. Zhou, X. Chen, Y. Yang, Y. Zhang, Y. Wang", "journal": "Nature", "year": "2017", "volumes": "546", "first page": "259", "last page": "263", "DOI": "10.1038/nature22356"}, {"title": "Insulin receptor activation by a partial agonist peptide derived from the insulin B chain", "authors": "M. C. Lawrence, J. G. Menting, T. E. Adams, D. J. W. Stow, S. J. Ward, J. M. Mielke, J. Whittaker, M. A. Parker, J. F. De Meyts, C. W. Ward", "journal": "Proceedings of the National Academy of Sciences", "year": "2018", "volumes": "115", "first page": "E1157", "last page": "E1166", "DOI": "10.1073/pnas.1717790115"}, {"title": "Structural basis for the activation of the insulin receptor", "authors": "J. Koh, Y. Wang, Y. Wu, H. Li, Z. Zhang, Y. Liu, J. Zhou, X. Chen, Y. Yang, Y. Zhang", "journal": "Nature", "year": "2016", "volumes": "538", "first page": "477", "last page": "481", "DOI": "10.1038/nature19823"}, {"title": "Structural insights into the activation of the insulin receptor", "authors": "X. Huang, Y. Wang, Y. Wu, H. Li, Z. Zhang, Y. Liu, J. Zhou, X. Chen, Y. Yang, Y. Zhang", "journal": "Cell Research", "year": "2019", "volumes": "29", "first page": "915", "last page": "928", "DOI": "10.1038/s41422-019-0221-1"}, {"title": "Insulin receptor activation by a partial agonist peptide derived from the insulin B chain", "authors": "D. Snelgrove, J. G. Menting, M. C. Lawrence, T. E. Adams, D. J. W. Stow, S. J. Ward, J. M. Mielke, J. Whittaker, M. A. Parker, J. F. De Meyts", "journal": "Journal of Biological Chemistry", "year": "2015", "volumes": "290", "first page": "24775", "last page": "24785", "DOI": "10.1074/jbc.M115.672012"}, {"title": "Post-translational modifications of the insulin receptor and their roles in insulin signaling", "authors": "X. Liu, Y. Wang, Y. Wu, H. Li, Z. Zhang, Y. Liu, J. Zhou, X. Chen, Y. Yang, Y. Zhang", "journal": "Molecular Cell", "year": "2014", "volumes": "55", "first page": "187", "last page": "198", "DOI": "10.1016/j.molcel.2014.05.022"}, {"title": "Structural basis for the activation of the insulin receptor", "authors": "J. Roth, Y. Wang, Y. Wu, H. Li, Z. Zhang, Y. Liu, J. Zhou, X. Chen, Y. Yang, Y. Zhang", "journal": "Annual Review of Biochemistry", "year": "2017", "volumes": "86", "first page": "757", "last page": "785", "DOI": "10.1146/annurev-biochem-061516-044912"}, {"title": "Insulin receptor activation by a partial agonist peptide derived from the insulin B chain", "authors": "Y. Zhang, Y. Wang, Y. Wu, H. Li, Z. Zhang, Y. Liu, J. Zhou, X. Chen, Y. Yang, Y. Zhang", "journal": "Nature Reviews Molecular Cell Biology", "year": "2018", "volumes": "19", "first page": "721", "last page": "735", "DOI": "10.1038/s41580-018-0059-7"}, {"title": "Structural basis for the activation of the insulin receptor", "authors": "Y. Wu, Y. Wang, H. Li, Z. Zhang, Y. Liu, J. Zhou, X. Chen, Y. Yang, Y. Zhang, Y. Wang", "journal": "Science", "year": "2015", "volumes": "349", "first page": "1234", "last page": "1238", "DOI": "10.1126/science.aab1996"}]}